An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Trabecular bone loss in estrogen deficiency is associated with enhanced bone resorption with a smaller increase in bone formation. We previously reported that low doses of strontium can increase trabecular bone volume in rodents by affecting bone resorption and formation. In this study we determined the effect of a new divalent strontium salt (S12911) on bone loss induced by E2 deficiency. Sprague-Dawley female rats (230 g, n = 15–25 per group) were sham operated or ovariectomized (OVX) and treated with 17β-estradiol (E2, 10 μg/kg/day, sc) or S12911 by gavage at the dose of 77, 154, or 308 mg/kg/day or the vehicle. Treatment for 60 days with S12911 resulted in a dose-dependent increase in plasma, urine, and bone strontium concentrations without any deleterious effect on total or skeletal growth. OVX rats were osteopenic compared to sham rats as shown by decreased femoral dry bone weight and mineral content measured on bone ash and by DXA. Treatment of OVX rats with S12911 prevented bone loss as bone ash and bone mineral content were restored to the values in sham rats. Trabecular bone volume measured by histomorphometry on the tibial metaphysis was decreased by 46% in OVX rats and was corrected by E2. Treatment of OVX rats with S12911 increased the trabecular bone volume by 30–36%. Histomorphometric indices of bone resorption (osteoclast surface and number) were increased in OVX rats and were reduced by S12911 to the levels in sham rats. In contrast to this inhibitory effect on bone resorption, the osteoid surface, osteoblast surface, mineral apposition rate, and bone formation rate were as high in OVX rats treated with S12911 as in untreated OVX rats. In addition, plasma osteocalcin (OC) and alkaline phosphatase (ALP) levels remained elevated or were further increased in OVX rats treated with S12911. In contrast, treatment with E2 reduced both bone resorption and formation and plasma ALP and OC to the levels in sham rats. The data indicate that the divalent strontium salt S12911 is acting as an uncoupling agent that can prevent the femoral osteopenia and partially prevent the trabecular bone loss in E2-deficient rats by inhibiting bone resorption without reducing bone formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,016
Bone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · Cited by 3,258
Riggs, B. L., & Melton, L. J. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606263142605 · Cited by 1,915
The ovariectomized rat model of postmenopausal bone loss
Kalu, D. N. (1991) · Bone and Mineral · doi:10.1016/0169-6009(91)90124-i · Cited by 1,361
LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGEN
Lindsay, R., Aitken, J. M., Anderson, L. B., Hart, D. M., Macdonald, E. B., & Clarke, A. C. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92217-0 · Cited by 952
OUTCOME FOR INFANTS OF VERY LOW BIRTHWEIGHT: SURVEY OF WORLD LITERATURE
STEWART, A. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92198-x · Cited by 830
Temporal relationship between bone loss and increased bone turnover in ovariectomized rats
Wronski, T. J., Cintrón, M., & Dann, L. M. (1988) · Calcified Tissue International · doi:10.1007/bf02571317 · Cited by 501
Parfitt, A. M. (1984) · Calcified Tissue International · doi:10.1007/bf02406145 · Cited by 441
The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats
Seedor, J. G., Quartuccio, H. A., & Thompson, D. D. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060405 · Cited by 407
Skeletal alterations in ovariectomized rats
Wronski, T. J., Lowry, P. L., Walsh, C. C., & Ignaszewski, L. A. (1985) · Calcified Tissue International · doi:10.1007/bf02554882 · Cited by 376
Cited by
Meunier, P. J., Roux, C., Seeman, E., Ortolani, S., Badurski, J. E., Spector, T. D., Cannata, J., Balogh, A., Lemmel, E.-M., Pors-Nielsen, S., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa022436 · Cited by 1,638
Bonnelye, E., Chabadel, A., Saltel, F., & Jurdic, P. (2008) · Bone · doi:10.1016/j.bone.2007.08.043 · Cited by 830
Mechanisms of Action and Therapeutic Potential of Strontium in Bone
Marie, P. J., Ammann, P., Boivin, G., & Rey, C. (2001) · Calcified Tissue International · doi:10.1007/s002230010055 · Cited by 689
Self-citationTreatment of postmenopausal osteoporosis
Delmas, P. D. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08827-x · Cited by 681
The effects of strontium-substituted bioactive glasses on osteoblasts and osteoclasts in vitro
Gentleman, E., Fredholm, Y. C., Jell, G., Lotfibakhshaiesh, N., O'Donnell, M. D., Hill, R. G., & Stevens, M. M. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.121 · Cited by 635
Treatment of Postmenopausal Osteoporosis
Eastell, R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803123381107 · Cited by 615
Incorporation and distribution of strontium in bone
Dahl, S. G., Allain, P., Marie, P. J., Mauras, Y., Boivin, G., Ammann, P., Tsouderos, Y., Delmas, P. D., & Christiansen, C. (2001) · Bone · doi:10.1016/s8756-3282(01)00419-7 · Cited by 590
Self-citationHow smart do biomaterials need to be? A translational science and clinical point of view
Holzapfel, B. M., Reichert, J. C., Schantz, J.-T., Gbureck, U., Rackwitz, L., Nöth, U., Jakob, F., Rudert, M., Groll, J., & Hutmacher, D. W. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.009 · Cited by 552
The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro
Canalis, E. (1996) · Bone · doi:10.1016/8756-3282(96)00080-4 · Cited by 498
Bioinorganics and biomaterials: Bone repair
Habibovic, P., & Barralet, J. E. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.03.027 · Cited by 441
Meunier, P. J. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.5.2060 · Cited by 337
Strontium signaling: Molecular mechanisms and therapeutic implications in osteoporosis
Saidak, Z., & Marie, P. J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.07.009 · Cited by 334
Self-citationThe Influence of Strontium on Bone Tissue Metabolism and Its Application in Osteoporosis Treatment
Kołodziejska, B., Stępień, N., & Kolmas, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126564 · Cited by 278
Peng, S., Zhou, G., Luk, K. D. K., Cheung, K. M. C., Li, Z., Lam, W. M., Zhou, Z., & Lu, W. W. (2009) · Cellular Physiology and Biochemistry · doi:10.1159/000204105 · Cited by 276
Ammann, P., Shen, V., Robin, B., Mauras, Y., Bonjour, J.-P., & Rizzoli, R. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040906 · Cited by 273
Osteoblasts in osteoporosis: Past, emerging, and future anabolic targets
Marie, P. J., & Kassem, M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0132 · Cited by 234
Self-citation
Metadata
- Authors
- Marie, P. J., Hott, M., Modrowski, D., De Pollak, C., Guillemain, J., Deloffre, P., & Tsouderos, Y.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1993-05-01
- Volume
- 8
- Issue
- 5
- Pages
- 607-615
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2005942823
- Cited by
- 385
- References
- 26
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.